Following the success of a University of Auckland-led pilot study examining castor oil as a treatment for dry eye disease, researchers are now looking for 90-plus participants for a larger, more robust study.
A new dry eye disease resource for patients is being launched at the University of Auckland on Saturday 13 April...
Ocular surface disease (OSD) is a multifactorial disorder of the conjunctival epithelium, cornea, lacrimal and meibomian glands resulting in either deficient or inappropriate tear production. This can decrease visual acuity (VA) and result in significant ocular discomfort1. OSD can occur in conjunct
In recent years, a lot more has been written about how menopause’s hormonal changes can have certain physical and mental effects. But how much do we know about how those changes can affect eye health? And is what we know about menopause and menopausal hormone therapy (MHT) enough to substantiate cha
Australian-based corporates are extending their service offerings with Specsavers piloting intense pulsed light (IPL) treatment for dry eye and George & Matilda embracing audiology.
Dusting off my PhD thesis recently, during a historical fact-finding mission, provided an opportunity to reflect on how far dry eye clinical care has come in the last 30 years.
Alcon has announced positive topline results from two pivotal phase 3 clinical trials (Comet-2 and Comet-3) evaluating the efficacy and safety of AR-15512, a candidate treatment for the signs and symp
Underpinning the advice an increasing number of ophthalmologists are putting into practice, Zeiss’ new Atlas 500 combines corneal topography and dry-eye assessment in one new piece of technology.
A novel cyclosporine drop formulation demonstrated significant improvement in corneal fluorescein staining (CFS) and in modified Symptom Assessment in Dry Eye (mSANDE) scores in patients with dry eye disease (DED), which was uncontrolled on Restasis (0.05% cyclosporine) therapy.
After a five-year hiatus and a shaky start due to inclement weather causing flight diversions and cancellations, Snowvision 2023 got underway with a traditional opening cocktail function in wintry
The optimal management of dry eye disease (DED) often seems an enigma. A recently published collaborative review, by Ocular Surface Laboratory (OSL) and Buchanan Ocular Therapeutics Unit (BOTU) researchers at the University of Auckland, outlined current anti-inflammatory options used in clinical man
Scleral lenses provide patients with many benefits and are an extremely useful adjunct in treating patients with ocular surface disease (OSD). Step three of the TFOS DEWS II report1 notes gas permeable scleral contact lenses (CLs) can be very beneficial to patients with moderate-to-severe dry eye di
